News and Updates

This article was written by Doug Lowenstein, whose daughter Emma was diagnosed with type 1 diabetes (T1D) in 2001 at age 14. He and his wife, Shelley Lowenstein, are long-time Breakthrough T1D supporters. Doug has worked as a Breakthrough T1D volunteer for 20+ years in the search for therapies to cure, prevent, and treat T1D. […]

This article was written by Loraine Brogan and her daughter Natalie Brogan, who lives with type 1 diabetes. Loraine and Natalie are both Participant Advisory Council (PAC) members, advocates, and long-time Breakthrough T1D supporters. This story details Natalie’s diagnosis, what research means to them, and their journey to the PAC. The views expressed by the […]

Disease-modifying therapies (DMTs) are treatments that prevent, slow, or reverse type 1 diabetes (T1D) by preserving or restoring insulin-producing beta cells. While there are several DMTs in clinical trials, there is only one that has been approved. A new Breakthrough T1D publication lays out how companies developing DMTs can incorporate strategic clinical trial design to […]

What’s Happening? A new Breakthrough T1D-funded clinical trial investigating Eledon Pharmeceuticals’ immunotherapy, tegoprubart, with islet cell transplants in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) just launched! This is the first time people with T1D and reduced kidney function are eligible for an islet cell therapy clinical trial—and the first person […]

Breakthrough T1D’s first-ever Clinical & Research Congress (CRC 2026), focused entirely on type 1 diabetes (T1D), has come to a close! Check out all our coverage below from the exciting weekend in Philadelphia, PA, where researchers, clinicians, industry leaders, healthcare professionals (HCPs), and the T1D community united to share updates across our entire mission. Check […]

It’s a rainy day in Philadelphia, but the mood at CRC 2026 could not be sunnier! The attendees are positively buzzing (seriously) with how timely and impactful this meeting is. It’s the right time for a meeting focused exclusively on type 1 diabetes (T1D), and the good news is we won’t have to wait years […]

We are two days into the first ever Breakthrough T1D Clinical & Research Congress! Day 1 was full of optimism and excitement about the meeting—it’s really ALL type 1 diabetes (T1D), which is unique—and the future of treatments and therapies for this community. Breakthrough T1D’s Clinical & Research Congress The inaugural Breakthrough T1D Clinical & […]

Hello from Philadelphia, PA! We could not be more thrilled that, after years and years, we have finally kicked off our inaugural Breakthrough T1D Clinical & Research Congress (CRC). This groundbreaking event is focused entirely on type 1 diabetes (T1D), and it’s happening right now! Breakthrough T1D’s Clinical & Research Congress The inaugural Breakthrough T1D […]

Heart and kidney complications remain a major concern for people living with type 1 diabetes (T1D). While there are some therapies available to reduce the risk of these complications, the T1D community urgently needs more options. SGLT inhibitors (SGLTi), which have proven effective in people with type 2 diabetes (T2D) and people without diabetes, are […]

After months and months of preparation, it’s finally here! Breakthrough T1D’s very first Clinical & Research Congress (CRC), a groundbreaking event focused entirely on type 1 diabetes (T1D), is happening this week from October 9-11 in Philadelphia, PA. Bringing Together People United in Our Shared Goal This scientific meeting is a groundbreaking event, uniting T1D […]